Cargando…
Extending varenicline preloading to 6 weeks facilitates smoking cessation: A single-site, randomised controlled trial
BACKGROUND: Initiating varenicline use 4 weeks before the target quit date (TQD) reduces smoking in the run-in phase and increases end-treatment cessation rates; however, the lack of a smoke intake plateau suggests longer preloading periods are required. This study assessed whether varenicline prelo...
Autores principales: | Bohadana, Abraham, Freier-Dror, Yossi, Peles, Vardit, Babai, Polina, Izbicki, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005428/ https://www.ncbi.nlm.nih.gov/pubmed/32055787 http://dx.doi.org/10.1016/j.eclinm.2019.11.021 |
Ejemplares similares
-
Early Detection of COPD: An Opportunistic Case Finding Study in Smokers and Ex-Smokers Visiting a Medical Centre
por: Rokach, Ariel, et al.
Publicado: (2021) -
Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008) -
Smoking cessation in Asians: focus on varenicline
por: Xiao, Dan, et al.
Publicado: (2015) -
Smoking cessation: an economic analysis and review of varenicline
por: Faulkner, Michele A
Publicado: (2009) -
Smoking cessation in Asians: focus on varenicline [Corrigendum]
Publicado: (2015)